Brief: Hcw Biologics Inc. Announces Its Lead Product Candidate Shown To Augment Anti-Tumor Activity And Reduce Side Effects Of Chemotherapy Regimens
20/01/2022 13:20
Jan 20 (Reuters) - HCW Biologics Inc HCWB.O :
* HCW BIOLOGICS INC. ANNOUNCES ITS LEAD PRODUCT CANDIDATE
SHOWN TO
AUGMENT ANTI-TUMOR ACTIVITY AND REDUCE SIDE EFFECTS OF
CHEMOTHERAPY REGIMENS
Source text for Eikon: ID:nGNXbc7kjZ
Further company coverage: HCWB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hcw Biologics
See all newsBrief: Hcw Biologics Maintains Momentum Toward Completion Of Ind Application For Clinical Study To Evaluate Lead T-Cell Engager In Solid Tumors
Brief: HCW Biologics Registers Resale Of Up To 1.81 Mln Shares Of Common Stock By Selling Stockholder- SEC Filing
NASDAQ RESUMED AT 10:34 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:29 AM
NASDAQ RESUMED AT 10:29 AM